Agenda
Thursday, December 13, 2012
Progress and Shortcomings of the Past Decade for R&D for Neglected Patients
| 8:00-9:00 am | BREAKFAST |
| 9:00-9:15 am | WELCOMING REMARKS – Philip Landrigan, MD, Dean of the Global Health Program at Mount Sinai School of Medicine – Deane Marchbein, MD, President of MSF-USA – Rachel Cohen, Regional Executive Director DNDi North America |
| 9:15-9:45 am | KEYNOTE ADDRESS Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases, US National Institutes of Health |
| 9:45-11:15 am | PANEL 1.1: Global Progress and Shortcomings of the Past Decade Panel Chair: Dyann Wirth, PhD, Richard Pearson Strong Professor of Infectious Diseases, Harvard School of Public Health Presenters: – Manica Balasegaram, MD, Executive Director, MSF Access Campaign – The urgent need for new tools for DR-TB – Julio A. Urbina, PhD, Venezuelan Institute for Scientific Research – Reaching neglected patients with Chagas treatment – F. Marc LaForce, MD, Director, Technical Services, Serum Institute of India, Ltd – Overview of vaccine initiatives of the past decade Discussants: – Atadjan Karimovich Khamraev, MD, Vice-Chairman of the Supreme Assembly of the Autonomous Republic of Karakalpakstan – Peter J. Hotez, MD, PhD, Dean, National School of Tropical Medicine, Baylor College of Medicine – H.E. Dr. Josephine Ojiambo, MB ChB, MPH, Ambassador, Deputy Permanent Representative of the Republic of Kenya to the United Nations |
| 11:15-11:30 am | BREAK |
| 11:30-1:00 pm | PANEL 1.2: New Tools and the R&D Landscape Panel Chair: Els Torreele, PhD, Director, Open Society Public Health Program’s Access to Essential Medicines Initiative Presenters: – Carlos Morel, MD DSc, Scientific Coordinator, Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation (Fiocruz) – What steps have been taken to address gaps in R&D for neglected patients over the last twenty years: A View from the South – Jean-Herve Bradol, MD, Research Director, MSF’s Centre de réflexion sur l’action et les savoirs humanitaires (CRASH) – Fatal Imbalance: Update and expanded review of new treatments and current pipeline of clinical trials for neglected diseases, 2000-2011 – John-Arne Røttingen, MD, PhD, Chair, Consultative expert working group on research and development (CEWG) – A possible framework for stimulating medical innovations for neglected patients Discussants: – Lucy Chesire, Director, TB ACTION Group, Kenya – James Love, Director, Knowledge Ecology International – Christian Loucq, MD, Director General International Vaccine Institute (IVI) |
| 1:00-2:00 pm | LUNCH |
HIGH LEVEL ROUNDTABLE DISCUSSIONS
| 2:00-3:30 pm | Opening Talk: Jim Y. Kim, MD, President, World Bank Group (Video Address) Roundtable 1.3: Setting Priorities for Global Health to Ensure Innovation and Access Moderator: Gavin Yamey, MD, MA, MRCP, Lead of E2Pi, the Evidence-to-Policy Initiative at the UCSF Global Health Group Panelists: – Carlos Gadelha, PhD, Secretary of Science, Technology and Strategic Products (SCTIE), Ministry of Health, Brazil – Marie-Paule Kieny, PhD, Assistant Director-General – Innovation, Information, Evidence and Research, World Health Organization – Dan Hartman, MD, Director, Integrated Development, Global Health Program, Bill & Melinda Gates Foundation – ‘Rolake Odetoyinbo, Director, Positive Action for Treatment Access (PATA), Nigeria Unni Karunakara, MD, International President of MSF |
| 3:30-3:45 pm | BREAK |
| 3:45-5:15 pm | Roundtable 1.4: Mechanisms for Facilitating Financing and Norm Setting Moderator: Ellen ‘t Hoen, LL.M., Research Fellow at the University of Amsterdam and Senior Advisor of the Medicines Patent Pool Panelists: – Roger I. Glass, MD, PhD, Director of the Fogarty International Center and Associate Director for International Research by NIH, US National Institutes of Health – Christopher A. Viehbacher, Chief Executive Officer, Sanofi – Gichinga Ndirangu, Africa Coordinator, Health Action International (HAI) – Samir K. Brahmachari, PhD, Director General, Council of Scientific and Industrial Research, India – Bernard Pecoul, MD, Executive Director of Drugs for Neglected Diseases initiative (DNDi) |
| 5:15-5:30 pm | Closing Remarks Marie-Pierre Allie, MD, President of MSF in France The need to accelerate the delivery of medical innovations to neglected patients |
Friday, December 14, 2012
How to Accelerate the Benefits from New Tools for DR-TB, Chagas disease, and Vaccines
| 8:00-8:55 am | BREAKFAST |
| 8:55-9:00 am | WELCOMING REMARKS Bennett Shapiro, PureTech Ventures and DNDi Board Member |
TECHNICAL SESSIONS
| 9:00-10:15 am | 2.1 DR TB Moderator: Arjan Hehenkamp, General Director, MSF Operational Center Amsterdam Short Presentations to set the stage: – Francis Varaine, MD, Head of MSF’s TB Working Group – Outcomes with current DR-TB treatment and urgent need for change – Mel Spigelman, MD, President and CEO, TB Alliance – The current pipeline and scheduled plans for when molecules will be available – Dalene von Delft, MD– A patient’s perspective of current DR-TB treatment Panel Discussion: – Atadjan Karimovich Khamraev, Vice-Chairman of the Supreme Assembly of the Autonomous Republic of Karakalpakstan – Carole Mitnick, ScD, Assistant Professor of Global Health and Social Medicine, Harvard Medical School – Mark Harrington, Executive Director, Treatment Action Group (TAG)Wim Parys, MD, Global Head, Infectious Diseases, Janssen Infectious Diseases BVBA |
| 10:15-10:30 am | BREAK |
| 10:30-11:45 am | 2.2. Chagas disease Moderator: Isabela Ribeiro, MD, Head of Chagas Clinical Program, DNDi Short Presentations Setting the Stage: – Jose Rivero, International Federation of People Suffering from Chagas Disease, Spain – A patient’s perspective of Chagas disease treatment – Carolina Batista, MSF Brazil and Henry Rodriguez, MD, MSF Head of Mission in Bolivia and Paraguay– Obstacles and challenges of treating Chagas disease – Faustino Torrico, M.D., Ph.D., Professor, Faculty of Medicine, Universidad Mayor de San Simon, Cochabamba, Bolivia – The current pipeline for Chagas disease Panel Discussion: – Jaime Lazovski, Secretary of Health Relations and Research, Ministry of Health, Argentina – Sheba Meymandi, MD, Director, Centre of Excellence for Chagas Disease, Olive View/UCLA Medical Center – Sonia Tarragona, General Director, Foundation Mundo Sano, Argentina – Pedro Alonso, MD, Director, Barcelona Center for International Health Research (CRESIB), University of Barcelona |
| 11:45-1:00 pm | 2.3. Vaccines Moderator: Robert Steinglass, Immunization Senior Advisor, John Snow, Inc. (JSI) and Immunization Team Leader, MCHIP Short Presentations Setting the Stage: – Samba Ousmane Sow, MD, Center for Vaccine Development-Mali (CVD-Mali) – A case study on using TT-Uniject in Mali – Rebecca Grais, PhD , Epicentre – Optimizing vaccinations in emergencies – what products are needed Panel Discussion: Fred Were, MD, Chairman of the Kenya Pediatric Association – F. Marc La Force, MD, Serum Institute of India – Nina Schwalbe, Managing Director, Policy & Performance, GAVI Alliance – Paul Herrling, PhD, Professor, Chair Novartis Institute for Tropical Diseases, Novartis Pharma AG |
| 1:00-1:10 pm | CLOSING REMARKS / CONFERENCE WRAP UP Marcel Tanner, PhD, Director of the Swiss Tropical and Public Health Institute and Chair of the Board of Directors, DNDi |
| 1:10 pm | LUNCH |
